MedCityNews INVEST PharmaTech - The State of AI in Drug Discovery

Artificial intelligence in healthcare is finally emerging from being overhyped to showing some practical applications. If it succeeds in the realms of drug discovery, that will be a monumental achievement helping both to speed up and lower the cost for drug development. Learn from experts about where we are in leveraging AI effectively for drug discovery.

Moderator: Frank Vinluan, Senior Biopharma Reporter, MedCity News
Speakers:
Nathan Benaich, PhD, Founder and General Partner, Air Street Capital @nathanbenaich
Chris Gibson, PhD, Co-founder and CEO, Recursion
Najat Khan, PhD, Chief Data Science Officer, Global Head, Strategy and Operations, Janssen Pharmaceutical
Richard Law, PhD, Chief Business Officer, Exscientia

[squamish]

It's weird how this hasn't been getting more attention. It's probably the biggest practical use of AI that has been developed so far, and yet LLMs have gobbled up all the attention.